BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6610200)

  • 1. The effect of continuous vasopressin infusion on splanchnic blood flow, liver function, and portal and central venous pressures in patients with cirrhosis.
    Ranek L; Vilstrup H; Iversen J; Petersen P; Milandri M
    Scand J Clin Lab Invest; 1984 May; 44(3):251-6. PubMed ID: 6610200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
    Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
    Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vasopressin on portal pressure during hemorrhage from esophageal varices.
    Ready JB; Robertson AD; Rector WG
    Gastroenterology; 1991 May; 100(5 Pt 1):1411-6. PubMed ID: 2013386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
    Møller S; Brinch K; Henriksen JH; Becker U
    J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of vasopressin in the management of bleeding esophageal varices.
    Schweitzer EJ; Kerr JC; Swan KG
    Am Surg; 1982 Nov; 48(11):558-62. PubMed ID: 6983321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow.
    Wisén E; Svennerholm K; Bown LS; Houltz E; Rizell M; Lundin S; Ricksten SE
    Acta Anaesthesiol Scand; 2018 Aug; 62(7):953-961. PubMed ID: 29578250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vasopressin on esophageal varices blood flow in patients with cirrhosis: comparisons with the effects on portal vein and superior mesenteric artery blood flow.
    Iwao T; Toyonaga A; Oho K; Shigemori H; Sakai T; Tayama C; Masumoto H; Sato M; Tanikawa K
    J Hepatol; 1996 Oct; 25(4):491-7. PubMed ID: 8912148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoproterenol in offsetting adverse effects of vasopressin in cirrhotic patients.
    Sirinek KR; Thomford NR
    Am J Surg; 1975 Feb; 129(2):130-6. PubMed ID: 1078945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasopressin on liver blood flow in the hypophysectomised rat.
    Jenkins SA; Mooney B; Taylor I; Shields R
    Digestion; 1984; 29(3):177-82. PubMed ID: 6745509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
    Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
    Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasopressin on regional splanchnic blood flows in conscious man.
    Erwald R; Wiechel KL; Strandell T
    Acta Chir Scand; 1976; 142(1):36-42. PubMed ID: 1266541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REDUCTION OF PORTAL VENOUS PRESSURE IN CIRRHOTIC PATIENTS WITH BLEEDING FROM OESOPHAGEAL VARICES, BY ADMINISTRATION OF A VASOPRESSIN DERIVATIVE, PHENYLALANINE-2-LYSINE-8-VASOPRESSIN.
    TSAKIRIS A; HAEMMERLI UP; BUEHLMANN A
    Am J Med; 1964 Jun; 36():825-39. PubMed ID: 14164148
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal hemorrhage.
    Tsai YT; Lee FY; Lin HC; Lee SD; Hsia HC; Lin WJ; Wang SS; Lay CS; Lai KH; Lo KJ
    Hepatology; 1991 Mar; 13(3):407-12. PubMed ID: 1999311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis.
    Eriksson LS; Law DH; Sato Y; Wahren J
    Clin Physiol; 1984 Feb; 4(1):5-11. PubMed ID: 6141861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
    Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
    Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo.
    Pomier-Layrargues G; Villeneuve JP; Willems B; Huet PM; Marleau D
    Gastroenterology; 1987 Dec; 93(6):1218-24. PubMed ID: 3315825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vasopressin on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
    Jenkins SA; Day DW; Mooney B; Devitt P; Baxter JN; Taylor I; Shields R
    Langenbecks Arch Chir; 1985; 365(2):135-46. PubMed ID: 4046683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of blood flow to vasopressin in the collateral left gastric vein in patients with portal hypertension.
    Matsutani S; Mizumoto H; Fukuzawa T; Ohto M; Okuda K
    J Hepatol; 1995 Nov; 23(5):557-62. PubMed ID: 8583144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of vasopressin action on splanchnic hemodynamics during bleeding: a study in conscious, portal hypertensive rats.
    Valla D; Girod C; Lee SS; Braillon A; Lebrec D
    Hepatology; 1988; 8(1):10-5. PubMed ID: 3257454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous versus superior mesenteric artery vasopressin infusions for the treatment of variceal bleeding.
    Burgener FA; Gutierrez OH
    Radiology; 1982 Mar; 142(3):769-72. PubMed ID: 6977790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.